Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,694.21 -6.72 -0.25%
FTSE 100 6,354.44 -19.77 -0.31%
DAX 8,231.77 +2.26 0.03%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Services

Miraca Holdings Inc

+ Add to Watchlist

4544:JP

4,480 JPY 80 1.82%

As of 02:00:00 ET on 06/19/2013.

Snapshot for Miraca Holdings Inc (4544)

Open: 4,470 Day's Range: 4,415 - 4,555 Volume: 123,800
Previous Close: 4,400 52wk Range: 3,015 - 5,180 1-Yr Rtn: +50.84%

Stock Chart for 4544

No chart data available.
  • 4544:JP 4,480
  • 1D
  • 1M
  • 1Y
4,400
Interactive 4544 Chart

Previous Close

Key Statistics for 4544

Current P/E Ratio (ttm) 17.5726
Estimated P/E(03/2014) 17.2155
Relative P/E vs. TPX 0.8341
Earnings Per Share (JPY) (ttm) 254.9420
Est. EPS (JPY) (03/2014) 260.2310
Est. PEG Ratio 1.4970
Market Cap (M JPY) 263,034.09
Shares Outstanding (M) 58.71
30 Day Average Volume 273,540
Price/Book (mrq) 1.9068
Price/Sale (ttm) 1.3597
Dividend Indicated Gross Yield 1.92%
Cash Dividend (JPY) 43.0000
Last Dividend 09/26/2013
5 Year Dividend Growth 12.70%
Next Earnings Announcement 08/02/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4544

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4544

Miraca Holdings Inc. develops, manufactures, exports, and imports clinical reagents, medical drugs, and medical equipment. The Company's clinical reagents are for cancer, malignant tumor, hypothyroidism, diabetes, and infectious diseases including AIDS. Miraca Holdings also conducts clinical tests for hospitals and medical organizations.

Hiromasa SuzukiPresidentShinji OgawaSenior Executive Officer
Hiromitsu TazawaSenior Executive OfficerTakeshi KoyamaExecutive Officer
More Company Profile & Key Executives for 4544

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil